Effect of Aqueous Moringa Oleifera (Lam) Leaf Extracts on Growth Performance and Carcass Characteristics of Hubbard Broiler Chicken

ABSTRACT Two hundred and forty day old broiler chicks were used to investigate the effect of aqueous Moringa oleifera leaf extracts (AMOLE) on growth performance and carcass characteristics of broiler chicken. The birds were randomly allocated into six treatments with four replicates, and each replicate containing 10 broiler chicks; the CRD was used. The treatments contained AMOLE0+ (positive control with antibiotic treatment), AMOLE0- (negative control with ordinary water), AMOLE60 (60 ml/l), AMOLE90 (90 ml/l), AMOLE120 (120 ml/l) and AMOLE150 (150 ml/l) inclusion levels of AMOLE, respectively. Birds on positive control had the highest final body weight and growth rate (2392.00 g and 53.61 g respectively) and the ones on 150 ml/l of AMOLE had the least (2042.00 g and 45.37 g respectively). Results of feed intake showed that birds on positive control had the highest (84.70 g) and the ones on 90 ml/litre of AMOLE had the lowest (73.19 g); while the results of feed conversion ratio indicated that birds on AMOLE90 and AMOLE120 performed better than the positive control treatment. Birds on the AMOLE had similar dressing percentages though that of positive control was highest (94.93 %); while those on AMOLE60 and AMOLE150 had the highest large intestine and lung weights respectively. Aqueous Moringa oleifera leaf extract can be included up to 90 ml/litre in the drinking water of broiler chicken for reduced feed intake (12.83 %) and improved feed conversion efficiency (9.11) thus, AMOLE can be used to replace synthetic antibiotics as growth promoter

Non-heartbeating donation of kidneys for transplantation.

There is a persistent shortage of kidneys available for transplantation. In the early 1980s, therefore, we published the concept of non-heartbeating (NHB) donation; that is, procurement of kidneys from donors whose death has been accompanied by irreversible circulatory arrest. NHB donors are generally categorized using four definitions; category III (awaiting cardiac arrest) and category IV (cardiac arrest while braindead)--or 'controlled'--donors are the most suitable for initiating NHB donation programs. Delayed graft function is associated with use of kidneys from such donors, but has no effect on graft survival in the short or long term. Use of kidneys from category I (dead upon arrival at hospital) and category II (unsuccessfully resuscitated), or 'uncontrolled', donors is likewise associated with delayed graft function, but also with an increased risk of primary nonfunction. Viability testing of donated organs from these sources is a prerequisite for transplantation. Machine preservation parameters and enzyme release measurements help to distinguish viable from nonviable kidneys. The proportion of NHB donor kidneys in the total pool of postmortem kidneys differs considerably between countries. In The Netherlands, the proportion is nearly 50%. This figure is markedly higher than that in the US and Canada, where national programs have now been initiated to increase rates of NHB donation. In the future, warm preservation techniques might facilitate better viability testing, thereby increasing NHB donation from category I and II donors and further reducing the shortage of kidneys available for transplantation